Blincyto.com receives about 2913 visitors in one month. That could possibly earn $14.57 each month or $0.49 each day. Server of the website is located in the United States. Blincyto.com main page was reached and loaded in 1.29 seconds. This is a good result. Try the services listed at the bottom of the page to search for available improvements.
Is blincyto.com legit? | |
Website Value | $263 |
Alexa Rank | 1606813 |
Monthly Visits | 2913 |
Daily Visits | 98 |
Monthly Earnings | $14.57 |
Daily Earnings | $0.49 |
Country: United States
Metropolitan Area: Boardman
Postal Reference Code: 97818
Latitude: 45.8491
Longitude: -119.7143
HTML Tag | Content | Informative? |
---|---|---|
Title: | Find Information About BLINCYTO® | Could be improved |
Description: | Find patient and HCP-focused information about BLINCYTO® (blinatumomab). Learn more about acute lymphoblastic leukemia (ALL). See Safety Info, including Boxed | |
H1: | An immunotherapy treatment that can help fight B-cell precursor ALL1 |
Results will appear here |
|
Pingdom - Web transfer-speed test from Pingdom
Run diagnostic transfer-rate tests on each page or individual page components (JS, .img, and HTML code) with Pingdom for blincyto.com
Google’s Web Analytics Google provides many analytical tools for the web that will help you find out the number of visitors, their locations and activities when logging onto blincyto.com
Alexa - blincyto.com on Alexa Traffic Rank Data
Alexa provides a charting service that shows global position by audience, engagement, and time spent on blincyto.com
Majestic Backlinks - Lookup other webpages that have hyperlinks leading to blincyto.com.
Google Index - Which of the pages is Google.com indexing?
Find out which pages from blincyto.com have made it into Google.com’s listings. You can find out with the "site:" query.
Website on this IP by Bing - All sites on the same 54.187.249.23 IP
View a list of websites with an IP matching that of blincyto.com from Bing.com
/patient/mrd/: | |
---|---|
Title |
BLINCYTO® (blinatumomab) Information for Patients |
Description |
Find patient info about BLINCYTO® (blinatumomab) and learn about MRD+ B-cell acute lymphoblastic leukemia (ALL). See Important Safety & Prescribing Info. |
H1 |
BLINCYTO® can eliminate detectable traces† of cancer2 |
H2 |
8 out of 10 patients (81%) had no detectable cancer after 4 weeks of therapy2,§,** |
/patient/rr/: | |
---|---|
Title |
BLINCYTO® (blinatumomab) for Patients |
Description |
Find patient-focused information about BLINCYTO® (blinatumomab), including a patient brochure and a doctor discussion guide. See Safety and Prescribing info. |
H1 |
BLINCYTO® was proven to help people live longer1 |
H2 |
People on BLINCYTO® lived nearly twice as long1 |
/hcp/mrd/: | |
---|---|
Title |
BLINCYTO® (blinatumomab) for HCPs | MRD+ B-cell ALL |
Description |
Find HCP info about BLINCYTO® (blinatumomab). Learn more about MRD+ B-cell acute lymphoblastic leukemia (ALL). See Important Safety & Prescribing Info. |
H1 |
Zero in on MRD |
H2 |
In the BLAST study, BLINCYTO® converted most patients to MRD–1,2 |
H3 |
Immediately following frontline induction therapy, move beyond complete remission1 |
/hcp/rr/: | |
---|---|
Title |
BLINCYTO® (blinatumomab) for HCPs | Landmark TOWER Phase 3 Study |
Description |
HCP info for BLINCYTO® (blinatumomab), indicated for treatment of relapsed or refractory acute lymphoblastic leukemia (ALL). See the Landmark TOWER Phase 3 study now. |
H2 |
INDICATION BLINCYTO® is indicated for the treatment of relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in s and children. [censored]
|
H3 |
IMPORTANT SAFETY INFORMATION |
Similar domain names
blincyto.xyzblind-adventures.comblind-alley.comblincwindows.comblincvision.comblinctechnology.com
You took 89.95 and 84.95 at the same time from my back account that i didnt authorize and was apparently hacked. I...